Mutations in IDH1 or IDH2 are disease-defining features of IDH-mutant and 1p/19q co-deleted oligodendroglioma and IDH-mutant astrocytoma [31]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).